Author

Tania Contente-Cuomo

Bioinnovation and Genome Sciences Division, Translational Genomics Research Institute, Phoenix, AZ, USA;

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1 Research Focus:variant calling· 1 Assay:whole-exome sequencing· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Adriana Marshall· 1 shared Alexandra Nazareno· 1 shared Alyssa Hernandez· 1 shared Ben Posorske· 1 shared David P. Carbone· 1 shared Floris P. Barthel· 1 shared Gwendolen Lorch· 1 shared Jason Hauptman· 1 shared

Activity by Year

2019-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adriana Marshall

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintNov 13, 2026

Multimodal Liquid Biopsy Improves Longitudinal Circulating Tumor DNA Detection in Children with Central Nervous System Tumors

Shea Gallus, Sharvari Mankame, Adriana Marshall…·Ross Mangum

This study evaluates a multimodal ctDNA detection approach in pediatric CNS tumors, finding improved detection rates in CSF compared to plasma and associations with survival outcomes.

DOI 10.64898/2026.11.11.766035

humanwhole-genome sequencing

𝕏 PostBluesky

Cancer BiologybioRxivPreprintFeb 25, 2019

Identification of frequent activating HER2 mutations in primary canine pulmonary adenocarcinoma

Gwendolen Lorch, Karthigayini Sivaprakasam, Victoria Zismann…·William P. D. Hendricks

This study identifies HER2 mutations in canine pulmonary adenocarcinomas, finding V659E mutations in 38% of cases and their association with drug sensitivity.

DOI 10.1101/528182

whole-exome sequencingexperimental assay

𝕏 PostBluesky